UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient enrollment expected to begin in Q4 2026UGN-501 is a ...
Medscape

Q&A: Can More Patients With MIBC Keep Their Bladder?

Rapid developments in muscle-invasive bladder cancer treatment are leading to new approaches to bladder preservation.
CNN

New ways to treat bladder cancer improve survival and shake up the standard of care, new studies show

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...
New York Post

J&J’s bladder cancer treatment approved by FDA — paving way for potential surgery-free option

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
Everyday Health

8 Treatments for Metastatic Bladder Cancer Pain

When bladder cancer metastasizes, it can cause pain in the areas it spreads to — mainly the lymph nodes, pelvis, lungs, liver, and bones. The severity of the pain can vary, too, depending on how ...

Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The ...
Cure Today

Reflections After Nine Years as a Bladder Cancer Survivor

Bladder cancer was diagnosed through cystoscopy, with initial treatment involving surgery and Bacillus Calmette-Guérin immunotherapy. Recurrence required further surgery. Shared exposure to ...